雌激素受体β基因CA重复序列多态性与绝经后骨质疏松症的关联性研究(英文)

被引:9
作者
耿力 [1 ]
姚珍薇 [1 ]
杨洪昌 [2 ]
骆建云 [1 ]
韩力力 [1 ]
卢起 [1 ]
机构
[1] 重庆医科大学附属第一医院妇产科
[2] 云南省创伤救治中心
关键词
骨质疏松症; 绝经后; 雌激素受体β(ESR2); 多态性; 骨密度;
D O I
暂无
中图分类号
R580 [];
学科分类号
摘要
绝经后骨质疏松症(PMO)是一种多基因调控的遗传性疾病。雌激素受体β亚型基因是骨质疏松症的重要侯选基因。此文采用病例对照设计(78名股骨颈PMO病人和122名对照以及108名腰椎PMO病人和92名对照)研究中国人(汉族)雌激素受体β基因(ESR2)第5内含子CA重复序列多态性与PMO的相关性。以CA重复序列平均数22次为界将重复序列基因分为短基因(<22)和长基因(≥22),分别以S和L表示。股骨颈及腰椎(L2-4)部位,病例组中LL基因型和L等位基因者频率显著高于对照组(P<0.01),SL、LL及SL+LL基因型者较SS基因型者患PMO风险显著增高(P<0.05);调整年龄、绝经时间、绝经年龄及体质指数后,Logistic回归分析显示ESR2(CA)n多态性仍然与股骨颈(OR4.923,95%CI1.986~12.203,P=0.001)及L2-4(OR2.267,95%CI1.121~4.598,P=0.023)PMO显著相关。结果显示:ESR2基因CA重复序列多态性与股骨颈和L2-4部位PMO独立关联,L等位基因显性影响PMO的发病风险。
引用
收藏
页码:868 / 876
页数:9
相关论文
共 7 条
[1]
Confirmation of linkage to chromosome 1q for peak vertebral bone mineral density in premenopausal white women [J].
Econs, MJ ;
Koller, DL ;
Hui, SL ;
Fishburn, T ;
Conneally, PM ;
Johnston, CC ;
Peacock, M ;
Foroud, TM .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (02) :223-228
[2]
Estrogen receptor β dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women [J].
Scariano, JK ;
Simplicio, SG ;
Montoya, GD ;
Garry, PJ ;
Baumgartner, RN .
CALCIFIED TISSUE INTERNATIONAL, 2004, 74 (06) :501-508
[3]
Estrogen receptor β gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern Chinese women [J].
Lau, HHL ;
Ho, AYY ;
Luk, KDK ;
Kung, AWC .
BONE, 2002, 31 (02) :276-281
[4]
Association of estrogen receptor β gene polymorphism with bone mineral density [J].
Ogawa, S ;
Hosoi, T ;
Shiraki, M ;
Orimo, H ;
Emi, M ;
Muramatsu, M ;
Ouchi, Y ;
Inoue, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) :537-541
[5]
Isolation and radiation hybrid mapping of dinucleotide repeat polymorphism at the human estrogen receptor β locus [J].
Tsukamoto, K ;
Inoue, S ;
Hosoi, T ;
Orimo, H ;
Emi, M .
JOURNAL OF HUMAN GENETICS, 1998, 43 (01) :73-74
[6]
The novel estrogen receptor- β subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens.[J]..FEBS Letters.1997, 1
[7]
ERβ: Identification and characterization of a novel human estrogen receptor.[J].Sietse Mosselman;Jan Polman;Rein Dijkema.FEBS Letters.1996, 1